Fighting fit for all his life, 86-year-old Alan Cooper has suffered three strokes in the last four years, with the most recent one only a few short months ago.

“All three times, I couldn’t move, stand up or speak. It’s a terrible feeling,” Alan said.

“When I had my first stroke I had an electrician at my home doing some work, I was laying down in my bed and couldn’t get up. I knew he was about to leave so I fell off the bed and tried to get to the door, just managing to open it so he could call the ambulance.

“The second time I was preparing food in the kitchen for some friends who were coming over and I collapsed. I had to drag myself into the lounge room so I was within sight and my friends could see me. The last stroke a few short months ago I was gardening and luckily one of my family members found me.”

The good news is, Alan is here today thanks to world-class research making incredible advances in the treatment and care of stroke patients. This is why we’re so proud to introduce you to our newest charitable affiliate to join the THRF Group, Cure for Stroke Australia which is dedicated to funding vital research to improve treatments and find a cure for stroke for people like Alan.

On each occasion Alan was rushed to the Royal Adelaide Hospital (RAH) where he was immediately seen by the world-class stroke team, led by Head of Stroke Associate Professor Tim Kleinig.

Whilst treated for all three strokes with thrombolysis, a procedure to dissolve the blood clot, during his last stroke in December 2017 Alan was also involved in a clinical trial testing an advanced clot busting drug. The most common form of stroke is caused by a clot blocking a vessel, but not all clots dissolve with the current approved medication. This trial is testing a newer medication which researchers hope will be more effective at unblocking arteries, while lessening the risk of bleeding into the brain (a rare but important side-effect of these treatments).

This is only one of many clinical trials the world-class stroke team have underway at the RAH’s Clinical Trial Centre, which we are so proud to support.

Now with the support of THRF and Cure for Stroke Australia, A/Prof Kleinig and his team are thrilled to continue their groundbreaking research in the hopes of saving more lives like Alan’s.

“Alan is a walking testament to modern stroke medicine and the power of research to improve patient treatments and outcomes,” A/Prof Kleinig said.

Whilst Alan has suffered permanent damage from his strokes, including losing function in his right hand that makes it difficult to write and damage to his vocal cord, he is incredibly grateful to A/Prof Kleinig and the expert team for not only saving his life, but also giving him a quality of life.

“It’s quite miraculous how they treat strokes now. They told me in the hospital that a third of my brain was affected by my last stroke so if they hadn’t got to it quickly I would have been a vegetable,” Alan said.

“I consider myself very lucky.”

support world-class stroke research

you may also like...

Revolutionary Stroke Research Saves Marilyn

After seeing her loving father suffer a debilitating stroke 50 years ago, Marilyn Jackson thought she would share the same fate when she suffered a stroke earlier this year. However, thanks to medical advancements, Marilyn’s stroke did not leave her with any debilitating side effects! read more

A Stroke of Luck

Avid Adelaide Crows supporters for 20 years, loving couple of 49 years Dawn and Robert Cunningham were travelling from their hometown in Port Pirie to Adelaide for the preliminary final between the Adelaide Crows and Geelong when the unthinkable happened – Robert suffered a stroke. read more

Crucial Treatment for Stroke Sufferers

In his recent study, Neurologist Dr Andrew Moey from The Queen Elizabeth Specialist Centre discovered a 4.5 per cent overall increase in the South Australian thrombolysis therapy (the breakdown of blood clots) rate for patients with stroke between the years 2008 and 2010. read more

Preventing and Treating Atrial Fibrillation

Atrial fibrillation can be a frightening and painful disorder to have. Heart palpitations, an elevated heart rate (without exercise) and shortness of breath are just some of the symptoms of this disorder, which affects between 10 and 15 per cent of people over the age of 65. Researchers at the Basil Hetzel Institute for Translational Health Research (BHI) have recently undertaken a study on the disorder to find out more about why it occurs and to develop effective treatments. read more

Life-saving Treatment for Stroke Victim – Rodney’s Story

Sixty-five-year-old Rodney Cotton calls himself one of the ‘lucky ones’. His story is one that demonstrates how research into Stroke has dramatically improved the lives of stroke victims and why The Queen Elizabeth Hospital’s dedicated Stroke Unit continues to draw national and international attention. read more